Skip to main content
SpringerLink
Log in

Polycystic Ovary Syndrome in Adolescent Girls

  • Chapter
  • First Online:
Puberty

  • 1753 Accesses

Abstract

Polycystic ovary syndrome (PCOS) is one of the most common disorders of hormonal imbalance in women of reproductive age. The signs and symptoms of PCOS, premature menarche, oligomenorrhea, amenorrhea, hirsutism, acne, and obesity, can occur as early as puberty. It is often difficult to diagnose PCOS in this patient population, however, because there is no current consensus on the diagnostic criteria in adolescent girls and because many of the hallmark signs and symptoms are similar to those that occur with puberty. In this chapter, we will focus on the disease particularly as it manifests in adolescent girls with emphasis on disease epidemiology, diagnostic criteria, pathogenesis, long-term complications, and management.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Stein Sr IF. The Stein–Leventhal syndrome: a curable form of sterility. N Engl J Med. 1958;259(9):420–3.

    Article  PubMed  Google Scholar 

  2. Dewailly D, et al. Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update. 2014;20(3):334–52.

    Article  CAS  PubMed  Google Scholar 

  3. Legro RS, et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(12):4565–92.

    Article  CAS  PubMed  Google Scholar 

  4. El-Sharkawy AA, et al. Effect of metformin on sleep disorders in adolescent girls with polycystic ovarian syndrome. J Pediatr Adolesc Gynecol. 2014;27(6):347–52.

    Article  PubMed  Google Scholar 

  5. De Leo V, et al. Metformin treatment is effective in obese teenage girls with PCOS. Hum Reprod. 2006;21(9):2252–6.

    Article  PubMed  Google Scholar 

  6. Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 2013;6:1–13.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Christensen SB, et al. Prevalence of polycystic ovary syndrome in adolescents. Fertil Steril. 2013;100(2):470–7.

    Article  PubMed  Google Scholar 

  8. Azziz R, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456–88.

    Article  PubMed  Google Scholar 

  9. Anderson AD, Solorzano CM, McCartney CR. Childhood obesity and its impact on the development of adolescent PCOS. Semin Reprod Med. 2014;32(3):202–13.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Mastorakos G, Lambrinoudaki I, Creatsas G. Polycystic ovary syndrome in adolescents: current and future treatment options. Paediatr Drugs. 2006;8(5):311–8.

    Article  PubMed  Google Scholar 

  11. Beltadze K, Barbakadze L. Diagnostic features of polycystic ovary syndrome in adolescents (review). Georgian Med News. 2015;238:32–4.

    Google Scholar 

  12. Azziz R. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. J Clin Endocrinol Metab. 2006;91(3):781–5.

    Article  CAS  PubMed  Google Scholar 

  13. Naderpoor N, et al. Obesity and polycystic ovary syndrome. Minerva Endocrinol. 2015;40(1):37–51.

    CAS  PubMed  Google Scholar 

  14. Trent M, et al. Overweight status of adolescent girls with polycystic ovary syndrome: body mass index as mediator of quality of life. Ambul Pediatr. 2005;5(2):107–11.

    Article  PubMed  Google Scholar 

  15. Vilmann LS, et al. Development of obesity and polycystic ovary syndrome in adolescents. Horm Res Paediatr. 2012;78(5–6):269–78.

    Article  CAS  PubMed  Google Scholar 

  16. Jonard S, Robert Y, Dewailly D. Revisiting the ovarian volume as a diagnostic criterion for polycystic ovaries. Hum Reprod. 2005;20(10):2893–8.

    Article  PubMed  Google Scholar 

  17. Li L, et al. Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents. J Pediatr Adolesc Gynecol. 2012;25(6):390–5.

    Article  PubMed  Google Scholar 

  18. Sultan C, Paris F. Clinical expression of polycystic ovary syndrome in adolescent girls. Fertil Steril. 2006;86 Suppl 1:S6.

    Article  PubMed  Google Scholar 

  19. Fauser BC, et al. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012;97(1):28–38. e25.

    Article  PubMed  Google Scholar 

  20. Chen Y, et al. The role of ovarian volume as a diagnostic criterion for Chinese adolescents with polycystic ovary syndrome. J Pediatr Adolesc Gynecol. 2008;21(6):347–50.

    Article  PubMed  Google Scholar 

  21. Yavuz Taslipinar M, et al. Endothelial dysfunction and insulin resistance in young women with polycystic ovarian syndrome. Turk J Med Sci. 2014;44(5):787–91.

    Article  CAS  PubMed  Google Scholar 

  22. Gonzalez F. Inflammation in polycystic ovary syndrome: underpinning of insulin resistance and ovarian dysfunction. Steroids. 2012;77(4):300–5.

    Article  CAS  PubMed  Google Scholar 

  23. Tomova A, et al. Anti-Mullerian hormone in women with polycystic ovary syndrome before and after therapy with metformin. Horm Metab Res. 2011;43(10):723–7.

    Article  CAS  PubMed  Google Scholar 

  24. Ridker PM, et al. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation. 2003;107(3):391–7.

    Article  PubMed  Google Scholar 

  25. Hannon TS, Janosky J, Arslanian SA. Longitudinal study of physiologic insulin resistance and metabolic changes of puberty. Pediatr Res. 2006;60(6):759–63.

    Article  CAS  PubMed  Google Scholar 

  26. Blank SK, et al. Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty. Semin Reprod Med. 2007;25(5):352–9.

    Article  CAS  PubMed  Google Scholar 

  27. Bruni V, et al. Polycystic ovary syndrome in adolescence. Ann N Y Acad Sci. 2010;1205:175–84.

    Article  CAS  PubMed  Google Scholar 

  28. Coviello AD, Legro RS, Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab. 2006;91(2):492–7.

    Article  CAS  PubMed  Google Scholar 

  29. Samy N, et al. Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index. Dis Markers. 2009;26(4):163–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Alemzadeh R, Kichler J, Calhoun M. Spectrum of metabolic dysfunction in relationship with hyperandrogenemia in obese adolescent girls with polycystic ovary syndrome. Eur J Endocrinol. 2010;162(6):1093–9.

    Article  CAS  PubMed  Google Scholar 

  31. Carreau AM, Baillargeon JP. PCOS in adolescence and type 2 diabetes. Curr Diab Rep. 2015;15(1):564.

    Article  PubMed  Google Scholar 

  32. Ormazabal P, et al. Testosterone modulates the expression of molecules linked to insulin action and glucose uptake in endometrial cells. Horm Metab Res. 2013;45(9):640–5.

    Article  CAS  PubMed  Google Scholar 

  33. Wells JC, Chomtho S, Fewtrell MS. Programming of body composition by early growth and nutrition. Proc Nutr Soc. 2007;66(3):423–34.

    Article  PubMed  Google Scholar 

  34. Glueck CJ, et al. Sex hormone-binding globulin, oligomenorrhea, polycystic ovary syndrome, and childhood insulin at age 14 years predict metabolic syndrome and class III obesity at age 24 years. J Pediatr. 2011;159(2):308–13. e2.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Rosenfield RL, et al. Antimullerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries. Fertil Steril. 2012;98(1):242–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Rosenfield RL. The polycystic ovary morphology-polycystic ovary syndrome spectrum. J Pediatr Adolesc Gynecol. 2015;28(6):412–9.

    Article  PubMed  Google Scholar 

  37. Isojarvi JI, et al. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med. 1993;329(19):1383–8.

    Article  CAS  PubMed  Google Scholar 

  38. Morrell MJ, et al. Hyperandrogenism, ovulatory dysfunction, and polycystic ovary syndrome with valproate versus lamotrigine. Ann Neurol. 2008;64(2):200–11.

    Article  CAS  PubMed  Google Scholar 

  39. Joffe H, et al. Valproate is associated with new-onset oligoamenorrhea with hyperandrogenism in women with bipolar disorder. Biol Psychiatry. 2006;59(11):1078–86.

    Article  CAS  PubMed  Google Scholar 

  40. Nelson-DeGrave VL, et al. Valproate potentiates androgen biosynthesis in human ovarian theca cells. Endocrinology. 2004;145(2):799–808.

    Article  CAS  PubMed  Google Scholar 

  41. Herzog AG. Temporolimbic epilepsy and polycystic ovary syndrome. Fertil Steril. 1996;65(1):210–11.

    Article  CAS  PubMed  Google Scholar 

  42. Joffe H, Hayes FJ. Menstrual cycle dysfunction associated with neurologic and psychiatric disorders: their treatment in adolescents. Ann N Y Acad Sci. 2008;1135:219–29.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Welt CK, Duran JM. Genetics of polycystic ovary syndrome. Semin Reprod Med. 2014;32(3):177–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Thathapudi S, et al. Association of luteinizing hormone chorionic gonadotropin receptor gene polymorphism (rs2293275) with polycystic ovarian syndrome. Genet Test Mol Biomarkers. 2015;19(3):128–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Sun M, et al. Correlation analysis between polycystic ovary syndrome susceptibility genes and metabolic phenotypes. Zhonghua Fu Chan Ke Za Zhi. 2014;49(6):441–5.

    PubMed  Google Scholar 

  46. Zhao H, et al. Family-based analysis of susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Hum Reprod. 2012;27(1):294–8.

    Article  CAS  PubMed  Google Scholar 

  47. Stankiewicz M, Norman R. Diagnosis and management of polycystic ovary syndrome: a practical guide. Drugs. 2006;66(7):903–12.

    Article  PubMed  Google Scholar 

  48. Williams RM, Ong KK, Dunger DB. Polycystic ovarian syndrome during puberty and adolescence. Mol Cell Endocrinol. 2013;373(1–2):61–7.

    Article  CAS  PubMed  Google Scholar 

  49. Glueck CJ, et al. Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents. Metabolism. 2006;55(4):508–14.

    Article  CAS  PubMed  Google Scholar 

  50. Senaldi L, et al. Is ultrasound useful in the diagnosis of adolescents with polycystic ovary syndrome? J Pediatr Endocrinol Metab. 2015;28(5–6):605–12.

    PubMed  Google Scholar 

  51. Broer SL, et al. Anti-Mullerian hormone: ovarian reserve testing and its potential clinical implications. Hum Reprod Update. 2014;20(5):688–701.

    Article  CAS  PubMed  Google Scholar 

  52. Powers SE, et al. Trends in standard workup performed by pediatric subspecialists for the diagnosis of adolescent polycystic ovary syndrome. J Pediatr Adolesc Gynecol. 2015;28(1):43–6.

    Article  PubMed  Google Scholar 

  53. Hoeger K, et al. The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials. J Clin Endocrinol Metab. 2008;93(11):4299–306.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Bridger T, et al. Randomized placebo-controlled trial of metformin for adolescents with polycystic ovary syndrome. Arch Pediatr Adolesc Med. 2006;160(3):241–6.

    Article  PubMed  Google Scholar 

  55. Genazzani AD, et al. Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia. Gynecol Endocrinol. 2007;23(3):146–52.

    Article  CAS  PubMed  Google Scholar 

  56. Spritzer PM, et al. Novel strategies in the management of polycystic ovary syndrome. Minerva Endocrinol. 2015;40(3):195–212.

    CAS  PubMed  Google Scholar 

  57. Ibanez L, de Zegher F. Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women. Hum Reprod Update. 2006;12(3):243–52.

    Article  CAS  PubMed  Google Scholar 

  58. Ibanez L, et al. Combined low-dose pioglitazone, flutamide, and metformin for women with androgen excess. J Clin Endocrinol Metab. 2007;92(5):1710–4.

    Article  CAS  PubMed  Google Scholar 

  59. Gacaferri Lumezi B, et al. Mixed form of hirsutism in an adolescent female and laser therapy. Iran Red Crescent Med J. 2014;16(6), e9410.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Mani H, Potdar N, Gleeson H. How to manage an adolescent girl presenting with features of polycystic ovary syndrome (PCOS); an exemplar for adolescent health care in endocrinology. Clin Endocrinol (Oxf). 2014;81(5):652–6.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Andrology Center, Cleveland Clinic, 10681 Carnegie Avenue, Cleveland, OH, 44195, USA

    Sajal Gupta

  2. Department of Urology, Cleveland Clinic, 10681 Carnegie Avenue, Cleveland, OH, 44195, USA

    Elizabeth Pandithurai

  3. American Center for Reproductive Medicine, Cleveland Clinic, Cleveland, OH, USA

    Ashok Agarwal

Authors
  1. Sajal Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elizabeth Pandithurai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ashok Agarwal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sajal Gupta .

Editor information

Editors and Affiliations

  1. Medical University Sofia, Sofia, Bulgaria

    Philip Kumanov

  2. American Center for Reproductive Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA

    Ashok Agarwal

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Gupta, S., Pandithurai, E., Agarwal, A. (2016). Polycystic Ovary Syndrome in Adolescent Girls. In: Kumanov, P., Agarwal, A. (eds) Puberty. Springer, Cham. https://doi.org/10.1007/978-3-319-32122-6_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-32122-6_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-32120-2

  • Online ISBN: 978-3-319-32122-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation